Home > News > AusBiotech 2010 Biotech Profile: Starpharma
October 25th, 2010
AusBiotech 2010 Biotech Profile: Starpharma
Abstract:
In an industry obsessed with finding the next big blockbuster, Melbourne-based Starpharma is using its technology platform to steadily accumulate wins in a broad range of markets.
Originally developed by the CSIRO's molecular research institute, Starpharma's dendrimer nanotechnology platform has seen the company sign licensing and co-development agreements with some of the world's largest pharmaceutical and medical technology companies, including Eli Lilly, Elanco and GlaxoSmithKline (GSK). In addition to developing new product pipelines, many of these companies are now applying Starpharma's technology towards improving the efficacy of existing products.
Source:
lifescientist.com.au
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
Nanobiotechnology
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||